
CSG Systems International Extraordinary General Meeting: Shareholders Back Key Proposals, Merger Actions

I'm PortAI, I can summarize articles.
Coeptis Therapeutics Holdings Incorporated held its Annual and Special Meeting of Stockholders virtually, presided by CEO Michael Mehalick. Key proposals included a merger-related share issuance, a spin-out of biopharmaceutical operations, a name change to Z Squared Inc., and a 2025 incentive compensation plan. Stockholders voted on nine proposals, with unanimous board support for each. The meeting also covered auditor ratification and an advisory vote on executive compensation. Preliminary results indicated a positive outcome for the proposals, with no need for adjournment expected.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

